SHULMAN JOSEPH (Chief Technical Officer) sold 53.4% of their position (9.75K shares) of RHYTHM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.12M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/3/2025ACC: 0001104659-25-105576
Officer· Chief Technical Officer
Since Feb 2022
-9.75K
Net shares
Net seller
$1.12M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9.75K acquired · 19.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.75K
Price / share
$30.66
Trade value
$298.87K
% of position
114.6%
10/30/2025
8.51K→18.26K
Common Stock
Direct
Shares
−9.75K
Price / share
$115.24
Trade value
$1.12M
% of position
53.4%
10/30/2025
18.26K→8.51K
Total
Net shares
+0.00
Net value
-$824.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/30/2025 | M · Option Exercise | +9.75K | $30.66 | $298.87K | 114.6% | 8.51K | 18.26K |
| Common Stock Direct | 10/30/2025 | S · Sale | −9.75K | $115.24 | $1.12M | 53.4% | 18.26K | 8.51K |
| Total | +0.00 | -$824.52K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
9.75K shares
Shares
−9.75K
Strike price
30.66
Held after
0.00
Exercisable
—
10/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock9.75K shares | 10/30/2025 | M · Option Exercise | −9.75K | 30.66 | — | 0.00 |